As of Feb 05
| +0.79 / +1.63%|
The 20 analysts offering 12-month price forecasts for Merck have a median target of 59.50, with a high estimate of 72.00 and a low estimate of 53.00. The median estimate represents a +20.49% increase from the last price of 49.38.
The current consensus among 23 polled investment analysts is to Hold stock in Merck. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.